Ose Immunotherapeutics

Developer of immunotherapies for immuno-oncology and autoimmune diseases

placeNantes, Pays De La Loire, France calendar_todayFounded 1986 groups61 employees language ose-immuno.com

Social engagement

Social engagement: 21K social following, 10 posts in the last 12 months — around the industry typical range.

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital150%
Bank & private debt150%

Recent activity

1 Jul 2026
Event
Assemblée Générale 2026
22 Jan 2026
Milestone
regulatory
22 Jan 2026
Milestone
regulatory
Coming soon